"谈谈这个问题!" 关于甲和布普伦诺芬的共享决策启动:通过社区参与型研究开发和初步评估对话援助
Elizabeth M Schoenfeld1,2, William E Soares1,2, Abigail L Girardin1
1Department of Emergency Medicine, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.
概括
这项研究改进了一种对话辅助工具,即谈论它 (TAI),以改善对阿片类药物使用障碍 (OUD) 的阿片类药物激动剂治疗 (OAT) 的获取. 这项与有实践经验的人一起开发的援助,显示出在紧急部门实施的巨大潜力.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 片激动剂治疗 (OAT) 对阿片类药物使用障碍 (OUD) 有效,但由于障碍,获取受到限制.
- 人际关系和知识差距阻碍了OAT的实施,特别是在紧急部门 (ED) 设置中.
研究的目的:
- 为了改进和评估一个对话辅助工具,谈论它 (TAI),以促进关于OUD治疗的共同决策.
- 通过将有生活经验的人 (PWLE) 参与开发过程,解决OAT的障碍.
主要方法:
- 使用了基于社区的参与式研究和定性方法.
- 一个多利益相关者指导委员会,采访和焦点小组为TAI对话辅助工具的代改进提供了信息.
- 用ED患者和OUD和临床医生进行β测试,然后对西班牙语翻译进行反,评估可接受性,适当性和可行性.
主要成果:
- 超过100名个人为TAI的改进和评估做出了贡献.
- 改进包括内容更改,语言简化,以及增加个人元素和资源.
- 经过验证的措施显示出高的实施潜力,ED患者在可接受性 (4.72),适当性 (4.70) 和可行性 (4.67) 上得分高.
结论:
- 谈论它 (TAI) 会话辅助工具是由PWLE,ED临床医生和成专家共同设计,改进和批准的.
- 该援助显示了改善OAT获取和实施的巨大潜力.
- 需要进一步的研究来评估TAI在临床实践中的有效性.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Phase II Reactions: Methylation Reactions
842
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
842
Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
Drug Abuse and Addiction: Pharmacological Phenomena
1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
Drug Administration and Therapy Phases: Overview
1.6K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
Therapeutic Drug Monitoring: Affecting Factors
307
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
307


